Please assess the completion status of the following clinical trial:

Trial Title: Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 60-85 years of age~* Female~* At least two years since last menstrual cycle~Exclusion Criteria:~* Abnormal or unexplained vaginal bleeding.~* Bone disorders, other than osteoporosis or low bone mass~* History of breast cancer, cancer of the uterus, or any cancer in the last five years (except skin cancer).~* History of cerebral vascular accidents or venous thromboembolic events~* Medications outlined

- Gender: FEMALE
- Minimum Age: 60 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).